Injectable / Weight Loss & GLP-1

GLP-1 Sema

GLP-1 Receptor Agonist · 5mg

GLP-1 Sema, injectable, front

$89 USD per unit · Coming soon · 5mg / 2mL vial

The gold standard in GLP-1 metabolic therapy. Pharmaceutical-grade semaglutide for sustainable weight management and glycemic optimization.

Product information

Semaglutide is a GLP-1 receptor agonist that mimics the incretin hormone GLP-1, reducing appetite and caloric intake through central and peripheral signaling. Our pharmaceutical-grade formulation delivers 5mg in a 2mL multi-dose vial with 99.5%+ purity verified by independent HPLC analysis.

Clinical research demonstrates significant reductions in body weight, HbA1c, and cardiovascular risk markers. Semaglutide works by slowing gastric emptying, enhancing satiety signaling, and supporting pancreatic beta-cell function.

Benefits

  • Appetite suppression via GLP-1 signaling
  • Sustainable weight management
  • Glycemic optimization
  • Cardiovascular risk reduction

Specifications

Fill / pack
5mg / 2mL vial
Format
Injectable
Serving
0.25-2.4mg weekly
Servings per container
4-8 weeks supply
Listed purity
99.68%
Molecular weight / composition
4113.58 Da
Storage
Refrigerate 2-8°C

View product certificate of analysis

Frequently asked questions

How should I store this product?

Refrigerate at 2-8°C. Keep away from direct light. Once reconstituted, use within 30 days.

How long until I see results?

Most users report initial effects within 2-4 weeks, with optimal results typically observed after 8-12 weeks of consistent use. Individual responses vary.

Is a Certificate of Analysis included?

Yes. Every order includes a batch-specific COA with HPLC purity analysis, amino acid sequence verification, and endotoxin testing results.

What injection method is recommended?

Subcutaneous injection is standard. Rotate injection sites. Detailed protocol guidance is available on every product page.

For laboratory and research use only. Not for human consumption.